PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7753765-3	1995	Exposure of GH3 cells to the inhibitor of intracellular Ca2+ mobilization, 8-(diethylamino)-octyl 3,4,5-trimethoxybenzoate hydrochloride (TMB-8) prevented the prolactin-releasing effect of remoxipride whereas pretreatment with the membrane Ca2+ channel antagonist nimodipine did not influence the response.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	138-143	prolactin	Rattus norvegicus	159-168	
3683076-0	1987	The intracellular calcium antagonist, TMB-8, inhibits prolactin gene expression in GH3 cells.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	38-43	prolactin	Rattus norvegicus	54-63	
3131117-12	1988	The effect of TMB-8 suggests that release of a small intracellular calcium pool may mediate the early actions of PRL in Nb2 cells.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	14-19	prolactin	Rattus norvegicus	113-116	
3683076-1	1987	We examined the effects of the drug, TMB-8, which promotes sequestration of intracellular Ca2+, on the ability of extracellular Ca2+ to stimulate prolactin gene expression in GH3 cells.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	37-42	prolactin	Rattus norvegicus	146-155	
3683076-2	1987	TMB-8 inhibited prolactin mRNA levels in a dose-dependent manner in the concentration range of 2.5-10 microM.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	0-5	prolactin	Rattus norvegicus	16-25	
3683076-6	1987	Both TMB-8 and the calmodulin inhibitor, calmidazolium, reversed the effects of Ca2+ on prolactin mRNA levels in cells that had been pretreated for 2 days with 0.4 mM CaCl2.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	5-10	prolactin	Rattus norvegicus	88-97